Table 1.
Baseline characteristics of patients enrolled in the trial
| Parameters | Total(277) | ANS(143) | ACS(134) | P-value (Two-tailed) |
|---|---|---|---|---|
| Sex(male/female) | 128/149 | (78/65) | (50/84) | 0.004* |
| Age (years) | 41.59 ± 13.26 | 45(35–54) | 35(27.75–47) | < 0.001# |
| CSF-T | 61.31 ± 290.06 | 14(7–31) | 7(5–12) | < 0.001# |
| CSF-WBC | 7.88 ± 25.90 | 5(3–10) | 3(2–4) | < 0.001# |
| CSF-Pro | 31.1 ± 14.91 | 32.3(24.1–42) | 25(17.93–34.05) | < 0.001# |
| CSF-G | 3.62 ± 0.69 | 3.46(3.24–3.71) | 3.56(3.27–3.84) | 0.212# |
| CSF-Cl | 125.72 ± 4.32 | 126.08 ± 2.2 | 125.75(124.48–127.2) | 0.179# |
When we grouped subjects, the WBC and protein in CSF were different, so we did not do the statistical analysis
CSF-T total number of cells in CSF, CSF-WBC white blood cells in CSF, CSF-Pro protein in CSF, CSF-G glucose in CSF, CSF-Cl chloride in CSF
Statistical analysis used in this table: *Independent sample t-test, two-tailed; #Non-parametric Mann–Whitney U-test